ATE312198T1 - Diagnose und behandlung von supravalvular aortic stenosis - Google Patents

Diagnose und behandlung von supravalvular aortic stenosis

Info

Publication number
ATE312198T1
ATE312198T1 AT94913974T AT94913974T ATE312198T1 AT E312198 T1 ATE312198 T1 AT E312198T1 AT 94913974 T AT94913974 T AT 94913974T AT 94913974 T AT94913974 T AT 94913974T AT E312198 T1 ATE312198 T1 AT E312198T1
Authority
AT
Austria
Prior art keywords
williams syndrome
elastin gene
elastin
diagnosis
gene
Prior art date
Application number
AT94913974T
Other languages
English (en)
Inventor
Mark T Keating
Mark F Leppert
Colleen A Morris
Original Assignee
Univ Utah Res Found
Univ Community College Sys Nev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found, Univ Community College Sys Nev filed Critical Univ Utah Res Found
Application granted granted Critical
Publication of ATE312198T1 publication Critical patent/ATE312198T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrotherapy Devices (AREA)
AT94913974T 1993-04-05 1994-04-04 Diagnose und behandlung von supravalvular aortic stenosis ATE312198T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4157693A 1993-04-05 1993-04-05
PCT/US1994/003426 WO1994023638A2 (en) 1993-04-05 1994-04-04 Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome

Publications (1)

Publication Number Publication Date
ATE312198T1 true ATE312198T1 (de) 2005-12-15

Family

ID=21917264

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05108543T ATE522621T1 (de) 1993-04-05 1994-04-04 Diagnose und behandlung von williams syndrom
AT94913974T ATE312198T1 (de) 1993-04-05 1994-04-04 Diagnose und behandlung von supravalvular aortic stenosis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05108543T ATE522621T1 (de) 1993-04-05 1994-04-04 Diagnose und behandlung von williams syndrom

Country Status (7)

Country Link
US (2) US5840489A (de)
EP (2) EP0694080B1 (de)
JP (1) JPH08512198A (de)
AT (2) ATE522621T1 (de)
CA (1) CA2158479C (de)
DE (1) DE69434566T2 (de)
WO (1) WO1994023638A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858662A (en) * 1993-04-05 1999-01-12 University Of Utah Research Foundation Diagnosis of Williams syndrome and Williams syndrome cognitive profile by analysis of the presence or absence of a LIM-kinase gene
US5672500A (en) * 1995-05-18 1997-09-30 Thomas Jefferson University Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
EP1064382B1 (de) 1998-03-17 2008-08-20 Genentech, Inc. Zu vegf und bmp1 homologe polypeptide
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU772452B2 (en) * 1999-06-25 2004-04-29 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Nucleic acid binding of multi-zinc finger transcription factors
US20030079236A1 (en) * 1999-09-10 2003-04-24 Comings David E. Polymorphisms associated with internalizing disorders
WO2001025433A2 (en) * 1999-10-07 2001-04-12 Genentech, Inc. Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
IL150987A0 (en) 2000-02-11 2003-02-12 Genentech Inc Novel inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
US6395488B1 (en) * 2000-04-28 2002-05-28 City Of Hope Cholecystokinin (CCK) gene as a risk factor for smoking in women
EP2792747A1 (de) 2000-06-23 2014-10-22 Genentech, Inc. Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Erkrankungen in Verbindung mit Angiogenese
EP2075253A1 (de) 2000-06-23 2009-07-01 Genentech, Inc. Methoden und Verbindungen zur Diagnose und Behandlung von Krankheiten, an denen Angiogenese beteiligt ist
US20050130149A1 (en) * 2001-10-25 2005-06-16 Osborne Lucy R. Method for williams-beuren syndrome diagnosis
AU2003228382A1 (en) * 2002-03-27 2003-10-13 University Of Utah Research Foundation Elastin prevents occlusion of body vessels by vascular smooth muscle cells
TWI299663B (en) * 2002-05-14 2008-08-11 Novartis Ag Methods of treatment
WO2004081186A2 (en) * 2003-03-10 2004-09-23 Applera Corporation Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof
CA2566257A1 (en) * 2004-05-07 2005-11-24 Applera Corporation Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof
WO2006132788A2 (en) 2005-06-06 2006-12-14 Genentech, Inc. Transgenic models for different genes and their use for gene characterization
EP1995321A2 (de) 2005-08-15 2008-11-26 Genentech, Inc. Neuartige Genunterbrechungen, dazugehörige Zusammensetzungen und Verfahren in Zusammenhang damit
WO2007081608A2 (en) 2005-11-21 2007-07-19 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
CA2638821A1 (en) 2006-02-17 2007-10-11 Genentech, Inc. Gene disruptons, compositions and methods relating thereto
CA2649387A1 (en) 2006-04-19 2008-03-27 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto

Also Published As

Publication number Publication date
US5650282A (en) 1997-07-22
WO1994023638A3 (en) 1994-12-08
US5840489A (en) 1998-11-24
DE69434566T2 (de) 2006-07-13
JPH08512198A (ja) 1996-12-24
EP0694080B1 (de) 2005-12-07
ATE522621T1 (de) 2011-09-15
EP0694080A4 (de) 1998-08-05
DE69434566D1 (de) 2006-01-12
EP1612280B1 (de) 2011-08-31
EP1612280A2 (de) 2006-01-04
EP0694080A1 (de) 1996-01-31
EP1612280A3 (de) 2009-05-20
WO1994023638A2 (en) 1994-10-27
CA2158479C (en) 2009-07-07
CA2158479A1 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
DE69434566D1 (de) Diagnose und behandlung von supravalvular aortic stenosis
Shulman et al. The evolution of disability in Parkinson disease
Kessing et al. Recurrence in affective disorder: analyses with frailty models
ATE182180T1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
DE69531004D1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
EP0870041A4 (de) KVLQT1 - EIN GEN DES LONG-QT-SYNDROMS, WELCHES FÜR KVLQT1 KODIERT UND WELCHES SICH MIT Mink ZUSAMMENSETZT, UM Iks-KALIUMKANÄLE DES HERZENS ZU BILDEN
Fromm et al. Oral health‐related quality of life, oral aesthetics and oral function in head and neck cancer patients after oral rehabilitation
ATE261497T1 (de) Diagnostisches verfahren und gerät
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
Jeffries et al. Bipolar spectrum disorder and fragile X syndrome: a family study.
Goodwin Knowledge about aging among physicians
RU2002134058A (ru) Способ дифференциальной диагностики типа деменции
Baloh et al. An appraisal of histochemical fiber types in Duchenne muscular dystrophy
SE8701437D0 (sv) Diagnostiskt forfarande in vitro samt medel som kan utnyttjas vid forfarandet
ATE80465T1 (de) Diagnose von fettleibigkeit, hervorgerufen durch eine genetische abnormalitaet, und verfahren zur therapeutischen behandlung von genetisch bedingter fettleibigkeit.
Eghbalieh et al. Prenatal stimulant exposure affects alerting and executive control in six and seven-year-olds
Krishan et al. 1980 recommendations of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.
SE9403953D0 (sv) Sequence-based diagnosis
Hu et al. EXPLORING THE USE OF MACHINE LEARNING TO IMPROVE DEMENTIA DETECTION: AUTOMATING CODING OF THE CLOCK-DRAWING TEST
Perlman Late-onset Tay-Sachs disease as a Friedreich ataxia phenocopy
Bironneau et al. Diagnostic des troubles psychiatriques en réanimation
Vaquero et al. Evaluation of mental state in a clinical trial of MARS for patients with acute hepatic encephalopathy: comparison of two scales
de Souza et al. Longitudinal neurocognitive outcomes in children with mild traumatic brain injury: An ABCD cohort analysis
Assem 25. Part 2. Tests for detecting drug allergy.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties